Top Markets
Coin of the day
Angion Biomedica Corp. Angion Biomedica Corp.

Angion Biomedica Corp.

ANGN
Clasificación en acciones #27863
Angion Biomedica Corp. operates as a biopharmaceutical enterprise,... Angion Biomedica Corp. operates as a biopharmaceutical enterprise, concentrating its efforts on the identification, advancement, and market introduction of small molecule treatments for severe organ damage and scarring conditions. Its primary investigational compound, ANG-3070, is an orally administered tyrosine kinase receptor inhibitor currently being developed to address fibrotic ailments, particularly those impacting the kidneys and lungs. The company's product pipeline also features ANG-3777, a hepatocyte growth factor mimetic engineered to treat acute organ injuries like delayed graft function, in addition to initiatives for ROCK2 inhibitors targeting fibrotic diseases and a CYP11B2 inhibitor program. Established in 1998, Angion Biomedica Corp. maintains its headquarters in Uniondale, New York.
Precio por acción
$1.00
Última sincronización: 2023-06-01
Capitalización bursátil
$30.11M
Cambio (1 día)
2.04%
Cambio (1 año)
0.00%
País
US
Comercio Angion Biomedica Corp. (ANGN)

Categoría

Historial del precio de la acción de Angion Biomedica Corp. (ANGN)
Precio más alto de cierre: $1.00 el 2023-06-01

Precio más bajo de cierre: $20.49 el 2021-02-01
Historial del precio de la acción de Angion Biomedica Corp. desde 2021 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2023 18.73%
2022 -70.78%
2021 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$759.01 6.64%
CH